219 related articles for article (PubMed ID: 29961688)
1. Monitoring of Osteonecrosis in Systemic Lupus Erythematosus: A Systematic Review and Metaanalysis.
Hussein S; Suitner M; Béland-Bonenfant S; Baril-Dionne A; Vandermeer B; Santesso N; Keeling S; Pope JE; Fifi-Mah A; Bourré-Tessier J
J Rheumatol; 2018 Oct; 45(10):1462-1476. PubMed ID: 29961688
[TBL] [Abstract][Full Text] [Related]
2. A meta-analysis of avascular necrosis in systemic lupus erythematosus: prevalence and risk factors.
Nevskaya T; Gamble MP; Pope JE
Clin Exp Rheumatol; 2017; 35(4):700-710. PubMed ID: 28240590
[TBL] [Abstract][Full Text] [Related]
3. The role of non-corticosteroid related factors in osteonecrosis (ON) in systemic lupus erythematosus: a nested case-control study of inception patients.
Prasad R; Ibanez D; Gladman D; Urowitz M
Lupus; 2007; 16(3):157-62. PubMed ID: 17432099
[TBL] [Abstract][Full Text] [Related]
4. Risk factors of systemic lupus erythematosus patients with pulmonary arterial hypertension: A systematic review and meta-analysis.
Lun X; Yang J; Liu Y; Zhao F; Wei Z; Sun Y; Zhou X
Medicine (Baltimore); 2023 Dec; 102(51):e36654. PubMed ID: 38134088
[TBL] [Abstract][Full Text] [Related]
5. Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus.
Keeling SO; Alabdurubalnabi Z; Avina-Zubieta A; Barr S; Bergeron L; Bernatsky S; Bourre-Tessier J; Clarke A; Baril-Dionne A; Dutz J; Ensworth S; Fifi-Mah A; Fortin PR; Gladman DD; Haaland D; Hanly JG; Hiraki LT; Hussein S; Legault K; Levy D; Lim L; Matsos M; McDonald EG; Medina-Rosas J; Pardo Pardi J; Peschken C; Pineau C; Pope J; Rader T; Reynolds J; Silverman E; Tselios K; Suitner M; Urowitz M; Touma Z; Vinet E; Santesso N
J Rheumatol; 2018 Oct; 45(10):1426-1439. PubMed ID: 30173152
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of cumulative corticosteroid dose and immunosuppressants on avascular necrosis in patients with systemic lupus erythematosus.
Kwon HH; Bang SY; Won S; Park Y; Yi JH; Joo YB; Lee HS; Bae SC
Lupus; 2018 Sep; 27(10):1644-1651. PubMed ID: 29950160
[TBL] [Abstract][Full Text] [Related]
7. Development of new osteonecrosis in systemic lupus erythematosus patients in association with long-term corticosteroid therapy after disease recurrence.
Nakamura J; Ohtori S; Sakamoto M; Chuma A; Abe I; Shimizu K
Clin Exp Rheumatol; 2010; 28(1):13-8. PubMed ID: 20346232
[TBL] [Abstract][Full Text] [Related]
8. Invasive fungal disease in systemic lupus erythematosus: a systematic review of disease characteristics, risk factors, and prognosis.
Wang LR; Barber CE; Johnson AS; Barnabe C
Semin Arthritis Rheum; 2014 Dec; 44(3):325-30. PubMed ID: 25129259
[TBL] [Abstract][Full Text] [Related]
9. Risk of osteonecrosis in systemic lupus erythematosus: An 11-year Chinese single-center cohort study.
Long Y; Zhang S; Zhao J; You H; Zhang L; Li J; Leng X; Wang Q; Tian X; Li M; Zeng X
Lupus; 2021 Aug; 30(9):1459-1468. PubMed ID: 34082592
[TBL] [Abstract][Full Text] [Related]
10. Suicidal behavior in patients with systematic lupus erythematosus: Systematic literature review and genetic linkage disequilibrium analysis.
Parperis K; Kyriakou A; Voskarides K; Chatzittofis A
Semin Arthritis Rheum; 2022 Jun; 54():151997. PubMed ID: 35344734
[TBL] [Abstract][Full Text] [Related]
11. [Clinical characteristics of 4 cases of scleritis associated with systemic lupus erythematosus].
Wang L; Yang Y; Jia Y; Miao H; Zhou YS; Zhang XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1081-1085. PubMed ID: 27987518
[TBL] [Abstract][Full Text] [Related]
12. [Aseptic necrosis in systemic lupus erythematosus].
Ishigatsubo Y; Kitamura H; Tani K; Narita M; Sakamoto H; Nagaoka S; Matsunaga K; Kato K; Chiba J; Tani S
Ryumachi; 1982 Aug; 22(4):286-92. PubMed ID: 7179024
[No Abstract] [Full Text] [Related]
13. Spontaneous repair of asymptomatic osteonecrosis associated with corticosteroid therapy in systemic lupus erythematosus: 10-year minimum follow-up with MRI.
Nakamura J; Harada Y; Oinuma K; Iida S; Kishida S; Takahashi K
Lupus; 2010 Oct; 19(11):1307-14. PubMed ID: 20605878
[TBL] [Abstract][Full Text] [Related]
14. Osteonecrosis in systemic lupus erythematosus, steroid-induced or a lupus-dependent manifestation?
Rascu A; Manger K; Kraetsch HG; Kalden JR; Manger B
Lupus; 1996 Aug; 5(4):323-7. PubMed ID: 8869906
[TBL] [Abstract][Full Text] [Related]
15. Systemic lupus erythematosus patients with high disease activity are associated with accelerated incidence of osteonecrosis: a systematic review and meta-analysis.
Zhang K; Zheng Y; Jia J; Ding J; Wu Z
Clin Rheumatol; 2018 Jan; 37(1):5-11. PubMed ID: 28948379
[TBL] [Abstract][Full Text] [Related]
16. [Osteonecrosis and systemic lupus erythematosus. Case with 5 localizations].
Marini R; Modena V
Reumatismo; 1976; 28(3):148-52. PubMed ID: 1031480
[No Abstract] [Full Text] [Related]
17. Relationship between osteonecrosis and antiphospholipid antibodies in patients with systemic lupus erythematosus: a systematic review protocol.
Wei Q; Zhou M; Liu J; Zhang S; Gao F; Lin H; Chen Z
BMJ Open; 2021 Jul; 11(7):e046163. PubMed ID: 34301653
[TBL] [Abstract][Full Text] [Related]
18. Features associated with pulmonary arterial hypertension in Chinese hospitalized systemic lupus erythematosus patients.
Xu SZ; Yan Liang ; Li XP; Li XM; Shuai ZW; Leng RX; Pan HF; Ye DQ
Clin Rheumatol; 2018 Jun; 37(6):1547-1553. PubMed ID: 29520672
[TBL] [Abstract][Full Text] [Related]
19. Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus.
Gladman DD; Urowitz MB; Chaudhry-Ahluwalia V; Hallet DC; Cook RJ
J Rheumatol; 2001 Apr; 28(4):761-5. PubMed ID: 11327247
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and risk factors of infection in patients with systemic lupus erythematosus: A systematic review and meta-analysis of observational studies.
Yuan Q; Xing X; Lu Z; Li X
Semin Arthritis Rheum; 2020 Oct; 50(5):1022-1039. PubMed ID: 32911280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
